Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin Chemotherapy for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: Results of ARM 1 of RTOG 0116

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 4, 2007, Pages 1081-1087

  Small Jr , William ^a   Winter, Kathryn ^b   Levenback, Charles ^c   Iyer, Revathy ^c   Gaffney, David ^d   Asbell, Sucha ^e   Erickson, Beth ^f   Jhingran, Anuja ^c   Greven, Kathy ^g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RTOG Statistical Center   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; Chemoradiation; Extended field radiotherapy; Toxicity

Indexed keywords

CERVICAL CANCER; CHEMORADIATION; EXTENDED-FIELD RADIOTHERAPY;

CHEMOTHERAPY; ONCOLOGY; RADIOTHERAPY; TOXICITY;

BIOMEDICAL ENGINEERING;

CISPLATIN; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING; BONE MARROW DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENDOCRINE DISEASE; EXTERNAL BEAM RADIOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEARING DISORDER; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; INFECTION; LEUKOPENIA; LIVER DISEASE; LUNG DISEASE; METASTASIS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NEUROPATHY; OTOTOXICITY; PAIN; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT DURATION; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 34447265272     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.026     Document Type: Article

References (25)

1. Pakin D.M., Bray F., Ferlay J., et al. Global cancer statisitics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Jemal A., Siegel R., Ward E., et al. Cancer statisitics, 2006. CA: Cancer J Clin 56 (2006) 106-130
3. Concurrent Chemoirradiation For Cervical Cancer, February 1999. National Cancer Institute Clinical Announcement-Direct Mailing: 1999;1-5.
4. Whitney C.W., Sause W., Bundy B.N., et al., A Gynecologic Oncology Group and Southwest Oncology Group Study. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. J Clin Oncol 17 (1999) 1339-1348
5. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
6. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
7. Peters III W.A., Liu P.Y., Barrett R.J., et al. Cisplatin and 5-Flrorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III intergroup study. J Clin Oncol 18 (2000) 1606-1613
8. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical cancer. N Engl J Med 340 (1999) 1154-1161
9. Berman M., Keys H.M., Creasman W., et al. Survival and patterns of recurrence in cervical cancer metastatic periaortic lymph nodes. Gynecol Oncol 19 (1984) 8-16
10. Lepanto P., Littman P., Mikuta J., et al. Treatment of para-aortic nodes in carcinoma of the cervix. Cancer 35 (1975) 1510-1513
11. Lovecchio J.L., Averette H.E., Doinato D., et al. 5-Year survival of patients with periaortic nodal metastases in clinical stage IB and II cervical carcinoma. Gynecol Oncol 34 (1989) 43-45
12. Nori D., Valentine E., and Hilaris B. The role of paraaortic node irradiation in the treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 211 (1985) 1469-1473
13. Tewfik H., et al. Para-aortic lymph node irradiation in carcinoma of the cervix after exploratory laparotomy and biopsy-proven positive aortic nodes. Int J Radiat Oncol Biol Phys 8 (1982) 13-18
14. Varia M., et al. Cervical carcinoma metastatic to para-aortic nodes: extended-field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecol Oncol Group Study. Int J Radiat Oncol Biol Phys 42 (1998) 1015-1023
15. Grigsby P.W., Heydon K., Mutch D.G., et al. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51 (2001) 982-987
16. Maltefano J., and Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph nodes metastases. Gynecol Oncol 42 (1991) 44-47
17. Podczaski E., Stryker J., Kaminski P., et al. Extended-field radiation therapy for carcinoma of the cervix. Cancer 66 (1990) 251-258
18. Sasse A.D., de Oliveira C.L.G., Sasse E.C., et al. Amifostine reduces side effects and improves complete response rate during radiotherapy: Results of a meta-analysis. Int J Radiol Oncol Biol Phys 64 (2006) 784-791
19. Kaplan E.L., and Meier P. Non-parametric estimation from incomplete observation. J Am Stat 53 (1958) 457-481
20. Grigsby P.W., Singh A.K., Siegel B.A., et al. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 59 (2004) 706-712
21. Cosin J.A., Fowler J.M., Chen M.D., et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 82 (1998) 2241-2248
22. Grigsby P.W., Siegel B.A., and Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol (2001) 3745-3749
23. Rose P.G., Adler L.P., Rodriguez M., et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopatholologic study. J Clin Oncol 17 (1999) 41-45
24. Sonoda Y., Leblanc E., Querleu D., et al. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol 91 (2003) 326-331
25. Mutic S., Malyapa R.S., Grigsby P.W., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55 (2003) 28-35